Roberto Scarafia

nipt tomalab roche roberto scarafia giuseppe simoni federico maggi francesca grati toma ariosa toma lab genoma perkin elmer francesca malvestiti barbara malvestiti toma advanced biomedical assays cell free genetic livia marcato molecular biology cffdna prenatal harmony nipd prenatalbobstm nipt ad alto rischio prenatal fetal screening fetalmed obstetrics and fetal medicine fetal screening diagnosi prenatale rscarafia r.scarafia rscarafia@tomalab.com toma spa subitance spectrum sczd ocd mdd2 mdd1 mdd maior mafd1 disorder depressive bipolar disorder autism anxiety adhd abuse perkin microdeletion elmer cfdna amniocentesis federico prefumo trattamenti registro responsività comploiance accountability trasparenza 679/2016 supersensibili sensibili gentica biometrici dati laboratorio sanita privacy garante comunicazione notifica rpd dpo screening f grati ultrasound villocentesis verifi gene single ngs yaron yuval manufacturer pcr health disorders francesca romana grati recurrent microduplication pregnancies pathogenic f. vialard pcvn karyotype micorarray toma advanced biomedical assays spa abnormal fetuses r scarafia human diagnosis microarray gestante eva pompilii grati 22q syndrome maggi simoni izzi toma

 * villocentesi mosaicismi feto-placentari mosaicismi

 * confirmatory amniocentesis feto-placentari interpreting feto-placental mosaicism tomalab

 * amniocentesi

 * cvs common aneuploidies diagnosis counseling counseling genetico beyond trisomy 21 trisomia 21 andrea lojacono first-trimester anomaly scan pregnancy advanced fetal ultrasound first trimester anomalies of the fetal abdomen waldo sepulveda